1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Venous Thromboembolism Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Factor Xa Inhibitors
        1.2.3 Direct Thrombin Inhibitors
        1.2.4 Heparin
        1.2.5 Vitamin K Antagonists
        1.2.6 Other
    1.3 Market by Application
        1.3.1 Global Venous Thromboembolism Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital Pharmacies
        1.3.3 Retail Pharmacies
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Venous Thromboembolism Therapeutics Market Perspective (2017-2028)
    2.2 Venous Thromboembolism Therapeutics Growth Trends by Region
        2.2.1 Venous Thromboembolism Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Venous Thromboembolism Therapeutics Historic Market Size by Region (2017-2022)
        2.2.3 Venous Thromboembolism Therapeutics Forecasted Market Size by Region (2023-2028)
    2.3 Venous Thromboembolism Therapeutics Market Dynamics
        2.3.1 Venous Thromboembolism Therapeutics Industry Trends
        2.3.2 Venous Thromboembolism Therapeutics Market Drivers
        2.3.3 Venous Thromboembolism Therapeutics Market Challenges
        2.3.4 Venous Thromboembolism Therapeutics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Venous Thromboembolism Therapeutics Players by Revenue
        3.1.1 Global Top Venous Thromboembolism Therapeutics Players by Revenue (2017-2022)
        3.1.2 Global Venous Thromboembolism Therapeutics Revenue Market Share by Players (2017-2022)
    3.2 Global Venous Thromboembolism Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Venous Thromboembolism Therapeutics Revenue
    3.4 Global Venous Thromboembolism Therapeutics Market Concentration Ratio
        3.4.1 Global Venous Thromboembolism Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Venous Thromboembolism Therapeutics Revenue in 2021
    3.5 Venous Thromboembolism Therapeutics Key Players Head office and Area Served
    3.6 Key Players Venous Thromboembolism Therapeutics Product Solution and Service
    3.7 Date of Enter into Venous Thromboembolism Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Venous Thromboembolism Therapeutics Breakdown Data by Type
    4.1 Global Venous Thromboembolism Therapeutics Historic Market Size by Type (2017-2022)
    4.2 Global Venous Thromboembolism Therapeutics Forecasted Market Size by Type (2023-2028)
5 Venous Thromboembolism Therapeutics Breakdown Data by Application
    5.1 Global Venous Thromboembolism Therapeutics Historic Market Size by Application (2017-2022)
    5.2 Global Venous Thromboembolism Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Venous Thromboembolism Therapeutics Market Size (2017-2028)
    6.2 North America Venous Thromboembolism Therapeutics Market Size by Type
        6.2.1 North America Venous Thromboembolism Therapeutics Market Size by Type (2017-2022)
        6.2.2 North America Venous Thromboembolism Therapeutics Market Size by Type (2023-2028)
        6.2.3 North America Venous Thromboembolism Therapeutics Market Share by Type (2017-2028)
    6.3 North America Venous Thromboembolism Therapeutics Market Size by Application
        6.3.1 North America Venous Thromboembolism Therapeutics Market Size by Application (2017-2022)
        6.3.2 North America Venous Thromboembolism Therapeutics Market Size by Application (2023-2028)
        6.3.3 North America Venous Thromboembolism Therapeutics Market Share by Application (2017-2028)
    6.4 North America Venous Thromboembolism Therapeutics Market Size by Country
        6.4.1 North America Venous Thromboembolism Therapeutics Market Size by Country (2017-2022)
        6.4.2 North America Venous Thromboembolism Therapeutics Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Venous Thromboembolism Therapeutics Market Size (2017-2028)
    7.2 Europe Venous Thromboembolism Therapeutics Market Size by Type
        7.2.1 Europe Venous Thromboembolism Therapeutics Market Size by Type (2017-2022)
        7.2.2 Europe Venous Thromboembolism Therapeutics Market Size by Type (2023-2028)
        7.2.3 Europe Venous Thromboembolism Therapeutics Market Share by Type (2017-2028)
    7.3 Europe Venous Thromboembolism Therapeutics Market Size by Application
        7.3.1 Europe Venous Thromboembolism Therapeutics Market Size by Application (2017-2022)
        7.3.2 Europe Venous Thromboembolism Therapeutics Market Size by Application (2023-2028)
        7.3.3 Europe Venous Thromboembolism Therapeutics Market Share by Application (2017-2028)
    7.4 Europe Venous Thromboembolism Therapeutics Market Size by Country
        7.4.1 Europe Venous Thromboembolism Therapeutics Market Size by Country (2017-2022)
        7.4.2 Europe Venous Thromboembolism Therapeutics Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Venous Thromboembolism Therapeutics Market Size (2017-2028)
    8.2 Asia-Pacific Venous Thromboembolism Therapeutics Market Size by Type
        8.2.1 Asia-Pacific Venous Thromboembolism Therapeutics Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Venous Thromboembolism Therapeutics Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Venous Thromboembolism Therapeutics Market Share by Type (2017-2028)
    8.3 Asia-Pacific Venous Thromboembolism Therapeutics Market Size by Application
        8.3.1 Asia-Pacific Venous Thromboembolism Therapeutics Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Venous Thromboembolism Therapeutics Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Venous Thromboembolism Therapeutics Market Share by Application (2017-2028)
    8.4 Asia-Pacific Venous Thromboembolism Therapeutics Market Size by Region
        8.4.1 Asia-Pacific Venous Thromboembolism Therapeutics Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Venous Thromboembolism Therapeutics Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Venous Thromboembolism Therapeutics Market Size (2017-2028)
    9.2 Latin America Venous Thromboembolism Therapeutics Market Size by Type
        9.2.1 Latin America Venous Thromboembolism Therapeutics Market Size by Type (2017-2022)
        9.2.2 Latin America Venous Thromboembolism Therapeutics Market Size by Type (2023-2028)
        9.2.3 Latin America Venous Thromboembolism Therapeutics Market Share by Type (2017-2028)
    9.3 Latin America Venous Thromboembolism Therapeutics Market Size by Application
        9.3.1 Latin America Venous Thromboembolism Therapeutics Market Size by Application (2017-2022)
        9.3.2 Latin America Venous Thromboembolism Therapeutics Market Size by Application (2023-2028)
        9.3.3 Latin America Venous Thromboembolism Therapeutics Market Share by Application (2017-2028)
    9.4 Latin America Venous Thromboembolism Therapeutics Market Size by Country
        9.4.1 Latin America Venous Thromboembolism Therapeutics Market Size by Country (2017-2022)
        9.4.2 Latin America Venous Thromboembolism Therapeutics Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Venous Thromboembolism Therapeutics Market Size (2017-2028)
    10.2 Middle East & Africa Venous Thromboembolism Therapeutics Market Size by Type
        10.2.1 Middle East & Africa Venous Thromboembolism Therapeutics Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Venous Thromboembolism Therapeutics Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Venous Thromboembolism Therapeutics Market Share by Type (2017-2028)
    10.3 Middle East & Africa Venous Thromboembolism Therapeutics Market Size by Application
        10.3.1 Middle East & Africa Venous Thromboembolism Therapeutics Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Venous Thromboembolism Therapeutics Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Venous Thromboembolism Therapeutics Market Share by Application (2017-2028)
    10.4 Middle East & Africa Venous Thromboembolism Therapeutics Market Size by Country
        10.4.1 Middle East & Africa Venous Thromboembolism Therapeutics Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Venous Thromboembolism Therapeutics Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Johnson & Johnson
        11.1.1 Johnson & Johnson Company Details
        11.1.2 Johnson & Johnson Business Overview
        11.1.3 Johnson & Johnson Venous Thromboembolism Therapeutics Introduction
        11.1.4 Johnson & Johnson Revenue in Venous Thromboembolism Therapeutics Business (2017-2022)
        11.1.5 Johnson & Johnson Recent Developments
    11.2 Sanofi
        11.2.1 Sanofi Company Details
        11.2.2 Sanofi Business Overview
        11.2.3 Sanofi Venous Thromboembolism Therapeutics Introduction
        11.2.4 Sanofi Revenue in Venous Thromboembolism Therapeutics Business (2017-2022)
        11.2.5 Sanofi Recent Developments
    11.3 Boehringer Ingelheim
        11.3.1 Boehringer Ingelheim Company Details
        11.3.2 Boehringer Ingelheim Business Overview
        11.3.3 Boehringer Ingelheim Venous Thromboembolism Therapeutics Introduction
        11.3.4 Boehringer Ingelheim Revenue in Venous Thromboembolism Therapeutics Business (2017-2022)
        11.3.5 Boehringer Ingelheim Recent Developments
    11.4 Daiichi Sankyo
        11.4.1 Daiichi Sankyo Company Details
        11.4.2 Daiichi Sankyo Business Overview
        11.4.3 Daiichi Sankyo Venous Thromboembolism Therapeutics Introduction
        11.4.4 Daiichi Sankyo Revenue in Venous Thromboembolism Therapeutics Business (2017-2022)
        11.4.5 Daiichi Sankyo Recent Developments
    11.5 Bristol-Myers Squibb (BMS)
        11.5.1 Bristol-Myers Squibb (BMS) Company Details
        11.5.2 Bristol-Myers Squibb (BMS) Business Overview
        11.5.3 Bristol-Myers Squibb (BMS) Venous Thromboembolism Therapeutics Introduction
        11.5.4 Bristol-Myers Squibb (BMS) Revenue in Venous Thromboembolism Therapeutics Business (2017-2022)
        11.5.5 Bristol-Myers Squibb (BMS) Recent Developments
    11.6 Bayer HealthCare
        11.6.1 Bayer HealthCare Company Details
        11.6.2 Bayer HealthCare Business Overview
        11.6.3 Bayer HealthCare Venous Thromboembolism Therapeutics Introduction
        11.6.4 Bayer HealthCare Revenue in Venous Thromboembolism Therapeutics Business (2017-2022)
        11.6.5 Bayer HealthCare Recent Developments
    11.7 Pfizer
        11.7.1 Pfizer Company Details
        11.7.2 Pfizer Business Overview
        11.7.3 Pfizer Venous Thromboembolism Therapeutics Introduction
        11.7.4 Pfizer Revenue in Venous Thromboembolism Therapeutics Business (2017-2022)
        11.7.5 Pfizer Recent Developments
    11.8 Leo Pharma
        11.8.1 Leo Pharma Company Details
        11.8.2 Leo Pharma Business Overview
        11.8.3 Leo Pharma Venous Thromboembolism Therapeutics Introduction
        11.8.4 Leo Pharma Revenue in Venous Thromboembolism Therapeutics Business (2017-2022)
        11.8.5 Leo Pharma Recent Developments
    11.9 Portola Pharmaceuticals
        11.9.1 Portola Pharmaceuticals Company Details
        11.9.2 Portola Pharmaceuticals Business Overview
        11.9.3 Portola Pharmaceuticals Venous Thromboembolism Therapeutics Introduction
        11.9.4 Portola Pharmaceuticals Revenue in Venous Thromboembolism Therapeutics Business (2017-2022)
        11.9.5 Portola Pharmaceuticals Recent Developments
    11.10 ThromboGenics
        11.10.1 ThromboGenics Company Details
        11.10.2 ThromboGenics Business Overview
        11.10.3 ThromboGenics Venous Thromboembolism Therapeutics Introduction
        11.10.4 ThromboGenics Revenue in Venous Thromboembolism Therapeutics Business (2017-2022)
        11.10.5 ThromboGenics Recent Developments
    11.11 Ionis Pharmaceuticals
        11.11.1 Ionis Pharmaceuticals Company Details
        11.11.2 Ionis Pharmaceuticals Business Overview
        11.11.3 Ionis Pharmaceuticals Venous Thromboembolism Therapeutics Introduction
        11.11.4 Ionis Pharmaceuticals Revenue in Venous Thromboembolism Therapeutics Business (2017-2022)
        11.11.5 Ionis Pharmaceuticals Recent Developments
    11.12 GlycoMimetics
        11.12.1 GlycoMimetics Company Details
        11.12.2 GlycoMimetics Business Overview
        11.12.3 GlycoMimetics Venous Thromboembolism Therapeutics Introduction
        11.12.4 GlycoMimetics Revenue in Venous Thromboembolism Therapeutics Business (2017-2022)
        11.12.5 GlycoMimetics Recent Developments
    11.13 BioInvent International
        11.13.1 BioInvent International Company Details
        11.13.2 BioInvent International Business Overview
        11.13.3 BioInvent International Venous Thromboembolism Therapeutics Introduction
        11.13.4 BioInvent International Revenue in Venous Thromboembolism Therapeutics Business (2017-2022)
        11.13.5 BioInvent International Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Venous Thromboembolism Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Factor Xa Inhibitors
    Table 3. Key Players of Direct Thrombin Inhibitors
    Table 4. Key Players of Heparin
    Table 5. Key Players of Vitamin K Antagonists
    Table 6. Key Players of Other
    Table 7. Global Venous Thromboembolism Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 8. Global Venous Thromboembolism Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Venous Thromboembolism Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global Venous Thromboembolism Therapeutics Market Share by Region (2017-2022)
    Table 11. Global Venous Thromboembolism Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global Venous Thromboembolism Therapeutics Market Share by Region (2023-2028)
    Table 13. Venous Thromboembolism Therapeutics Market Trends
    Table 14. Venous Thromboembolism Therapeutics Market Drivers
    Table 15. Venous Thromboembolism Therapeutics Market Challenges
    Table 16. Venous Thromboembolism Therapeutics Market Restraints
    Table 17. Global Venous Thromboembolism Therapeutics Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global Venous Thromboembolism Therapeutics Revenue Share by Players (2017-2022)
    Table 19. Global Top Venous Thromboembolism Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Venous Thromboembolism Therapeutics as of 2021)
    Table 20. Ranking of Global Top Venous Thromboembolism Therapeutics Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by Venous Thromboembolism Therapeutics Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Venous Thromboembolism Therapeutics Product Solution and Service
    Table 24. Date of Enter into Venous Thromboembolism Therapeutics Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Venous Thromboembolism Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global Venous Thromboembolism Therapeutics Revenue Market Share by Type (2017-2022)
    Table 28. Global Venous Thromboembolism Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global Venous Thromboembolism Therapeutics Revenue Market Share by Type (2023-2028)
    Table 30. Global Venous Thromboembolism Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global Venous Thromboembolism Therapeutics Revenue Share by Application (2017-2022)
    Table 32. Global Venous Thromboembolism Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global Venous Thromboembolism Therapeutics Revenue Share by Application (2023-2028)
    Table 34. North America Venous Thromboembolism Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 35. North America Venous Thromboembolism Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 36. North America Venous Thromboembolism Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 37. North America Venous Thromboembolism Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 38. North America Venous Thromboembolism Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 39. North America Venous Thromboembolism Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Europe Venous Thromboembolism Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 41. Europe Venous Thromboembolism Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 42. Europe Venous Thromboembolism Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 43. Europe Venous Thromboembolism Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 44. Europe Venous Thromboembolism Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 45. Europe Venous Thromboembolism Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 46. Asia Pacific Venous Thromboembolism Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 47. Asia Pacific Venous Thromboembolism Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Venous Thromboembolism Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Venous Thromboembolism Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 50. Asia Pacific Venous Thromboembolism Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 51. Asia Pacific Venous Thromboembolism Therapeutics Market Size by Region (2023-2028) & (US$ Million)
    Table 52. Latin America Venous Thromboembolism Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 53. Latin America Venous Thromboembolism Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 54. Latin America Venous Thromboembolism Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 55. Latin America Venous Thromboembolism Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 56. Latin America Venous Thromboembolism Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 57. Latin America Venous Thromboembolism Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Venous Thromboembolism Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa Venous Thromboembolism Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Venous Thromboembolism Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Venous Thromboembolism Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 62. Middle East and Africa Venous Thromboembolism Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 63. Middle East and Africa Venous Thromboembolism Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 64. Johnson & Johnson Company Details
    Table 65. Johnson & Johnson Business Overview
    Table 66. Johnson & Johnson Venous Thromboembolism Therapeutics Product
    Table 67. Johnson & Johnson Revenue in Venous Thromboembolism Therapeutics Business (2017-2022) & (US$ Million)
    Table 68. Johnson & Johnson Recent Developments
    Table 69. Sanofi Company Details
    Table 70. Sanofi Business Overview
    Table 71. Sanofi Venous Thromboembolism Therapeutics Product
    Table 72. Sanofi Revenue in Venous Thromboembolism Therapeutics Business (2017-2022) & (US$ Million)
    Table 73. Sanofi Recent Developments
    Table 74. Boehringer Ingelheim Company Details
    Table 75. Boehringer Ingelheim Business Overview
    Table 76. Boehringer Ingelheim Venous Thromboembolism Therapeutics Product
    Table 77. Boehringer Ingelheim Revenue in Venous Thromboembolism Therapeutics Business (2017-2022) & (US$ Million)
    Table 78. Boehringer Ingelheim Recent Developments
    Table 79. Daiichi Sankyo Company Details
    Table 80. Daiichi Sankyo Business Overview
    Table 81. Daiichi Sankyo Venous Thromboembolism Therapeutics Product
    Table 82. Daiichi Sankyo Revenue in Venous Thromboembolism Therapeutics Business (2017-2022) & (US$ Million)
    Table 83. Daiichi Sankyo Recent Developments
    Table 84. Bristol-Myers Squibb (BMS) Company Details
    Table 85. Bristol-Myers Squibb (BMS) Business Overview
    Table 86. Bristol-Myers Squibb (BMS) Venous Thromboembolism Therapeutics Product
    Table 87. Bristol-Myers Squibb (BMS) Revenue in Venous Thromboembolism Therapeutics Business (2017-2022) & (US$ Million)
    Table 88. Bristol-Myers Squibb (BMS) Recent Developments
    Table 89. Bayer HealthCare Company Details
    Table 90. Bayer HealthCare Business Overview
    Table 91. Bayer HealthCare Venous Thromboembolism Therapeutics Product
    Table 92. Bayer HealthCare Revenue in Venous Thromboembolism Therapeutics Business (2017-2022) & (US$ Million)
    Table 93. Bayer HealthCare Recent Developments
    Table 94. Pfizer Company Details
    Table 95. Pfizer Business Overview
    Table 96. Pfizer Venous Thromboembolism Therapeutics Product
    Table 97. Pfizer Revenue in Venous Thromboembolism Therapeutics Business (2017-2022) & (US$ Million)
    Table 98. Pfizer Recent Developments
    Table 99. Leo Pharma Company Details
    Table 100. Leo Pharma Business Overview
    Table 101. Leo Pharma Venous Thromboembolism Therapeutics Product
    Table 102. Leo Pharma Revenue in Venous Thromboembolism Therapeutics Business (2017-2022) & (US$ Million)
    Table 103. Leo Pharma Recent Developments
    Table 104. Portola Pharmaceuticals Company Details
    Table 105. Portola Pharmaceuticals Business Overview
    Table 106. Portola Pharmaceuticals Venous Thromboembolism Therapeutics Product
    Table 107. Portola Pharmaceuticals Revenue in Venous Thromboembolism Therapeutics Business (2017-2022) & (US$ Million)
    Table 108. Portola Pharmaceuticals Recent Developments
    Table 109. ThromboGenics Company Details
    Table 110. ThromboGenics Business Overview
    Table 111. ThromboGenics Venous Thromboembolism Therapeutics Product
    Table 112. ThromboGenics Revenue in Venous Thromboembolism Therapeutics Business (2017-2022) & (US$ Million)
    Table 113. ThromboGenics Recent Developments
    Table 114. Ionis Pharmaceuticals Company Details
    Table 115. Ionis Pharmaceuticals Business Overview
    Table 116. Ionis Pharmaceuticals Venous Thromboembolism Therapeutics Product
    Table 117. Ionis Pharmaceuticals Revenue in Venous Thromboembolism Therapeutics Business (2017-2022) & (US$ Million)
    Table 118. Ionis Pharmaceuticals Recent Developments
    Table 119. GlycoMimetics Company Details
    Table 120. GlycoMimetics Business Overview
    Table 121. GlycoMimetics Venous Thromboembolism Therapeutics Product
    Table 122. GlycoMimetics Revenue in Venous Thromboembolism Therapeutics Business (2017-2022) & (US$ Million)
    Table 123. GlycoMimetics Recent Developments
    Table 124. BioInvent International Company Details
    Table 125. BioInvent International Business Overview
    Table 126. BioInvent International Venous Thromboembolism Therapeutics Product
    Table 127. BioInvent International Revenue in Venous Thromboembolism Therapeutics Business (2017-2022) & (US$ Million)
    Table 128. BioInvent International Recent Developments
    Table 129. Research Programs/Design for This Report
    Table 130. Key Data Information from Secondary Sources
    Table 131. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Venous Thromboembolism Therapeutics Market Share by Type: 2021 VS 2028
    Figure 2. Factor Xa Inhibitors Features
    Figure 3. Direct Thrombin Inhibitors Features
    Figure 4. Heparin Features
    Figure 5. Vitamin K Antagonists Features
    Figure 6. Other Features
    Figure 7. Global Venous Thromboembolism Therapeutics Market Share by Application: 2021 VS 2028
    Figure 8. Hospital Pharmacies Case Studies
    Figure 9. Retail Pharmacies Case Studies
    Figure 10. Other Case Studies
    Figure 11. Venous Thromboembolism Therapeutics Report Years Considered
    Figure 12. Global Venous Thromboembolism Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 13. Global Venous Thromboembolism Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Venous Thromboembolism Therapeutics Market Share by Region: 2021 VS 2028
    Figure 15. Global Venous Thromboembolism Therapeutics Market Share by Players in 2021
    Figure 16. Global Top Venous Thromboembolism Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Venous Thromboembolism Therapeutics as of 2021)
    Figure 17. The Top 10 and 5 Players Market Share by Venous Thromboembolism Therapeutics Revenue in 2021
    Figure 18. North America Venous Thromboembolism Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 19. North America Venous Thromboembolism Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 20. North America Venous Thromboembolism Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 21. North America Venous Thromboembolism Therapeutics Market Size Share by Country (2017-2028)
    Figure 22. United States Venous Thromboembolism Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Canada Venous Thromboembolism Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Europe Venous Thromboembolism Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 25. Europe Venous Thromboembolism Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 26. Europe Venous Thromboembolism Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 27. Europe Venous Thromboembolism Therapeutics Market Size Share by Country (2017-2028)
    Figure 28. Germany Venous Thromboembolism Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. France Venous Thromboembolism Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. U.K. Venous Thromboembolism Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Italy Venous Thromboembolism Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Russia Venous Thromboembolism Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Nordic Countries Venous Thromboembolism Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Asia-Pacific Venous Thromboembolism Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 35. Asia Pacific Venous Thromboembolism Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 36. Asia Pacific Venous Thromboembolism Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 37. Asia Pacific Venous Thromboembolism Therapeutics Market Size Share by Region (2017-2028)
    Figure 38. China Venous Thromboembolism Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Japan Venous Thromboembolism Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. South Korea Venous Thromboembolism Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Southeast Asia Venous Thromboembolism Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. India Venous Thromboembolism Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Australia Venous Thromboembolism Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 44. Latin America Venous Thromboembolism Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 45. Latin America Venous Thromboembolism Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 46. Latin America Venous Thromboembolism Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 47. Latin America Venous Thromboembolism Therapeutics Market Size Share by Country (2017-2028)
    Figure 48. Mexico Venous Thromboembolism Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Brazil Venous Thromboembolism Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 50. Middle East & Africa Venous Thromboembolism Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 51. Middle East and Africa Venous Thromboembolism Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 52. Middle East and Africa Venous Thromboembolism Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 53. Middle East and Africa Venous Thromboembolism Therapeutics Market Size Share by Country (2017-2028)
    Figure 54. Turkey Venous Thromboembolism Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. Saudi Arabia Venous Thromboembolism Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. UAE Venous Thromboembolism Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 57. Johnson & Johnson Revenue Growth Rate in Venous Thromboembolism Therapeutics Business (2017-2022)
    Figure 58. Sanofi Revenue Growth Rate in Venous Thromboembolism Therapeutics Business (2017-2022)
    Figure 59. Boehringer Ingelheim Revenue Growth Rate in Venous Thromboembolism Therapeutics Business (2017-2022)
    Figure 60. Daiichi Sankyo Revenue Growth Rate in Venous Thromboembolism Therapeutics Business (2017-2022)
    Figure 61. Bristol-Myers Squibb (BMS) Revenue Growth Rate in Venous Thromboembolism Therapeutics Business (2017-2022)
    Figure 62. Bayer HealthCare Revenue Growth Rate in Venous Thromboembolism Therapeutics Business (2017-2022)
    Figure 63. Pfizer Revenue Growth Rate in Venous Thromboembolism Therapeutics Business (2017-2022)
    Figure 64. Leo Pharma Revenue Growth Rate in Venous Thromboembolism Therapeutics Business (2017-2022)
    Figure 65. Portola Pharmaceuticals Revenue Growth Rate in Venous Thromboembolism Therapeutics Business (2017-2022)
    Figure 66. ThromboGenics Revenue Growth Rate in Venous Thromboembolism Therapeutics Business (2017-2022)
    Figure 67. Ionis Pharmaceuticals Revenue Growth Rate in Venous Thromboembolism Therapeutics Business (2017-2022)
    Figure 68. GlycoMimetics Revenue Growth Rate in Venous Thromboembolism Therapeutics Business (2017-2022)
    Figure 69. BioInvent International Revenue Growth Rate in Venous Thromboembolism Therapeutics Business (2017-2022)
    Figure 70. Bottom-up and Top-down Approaches for This Report
    Figure 71. Data Triangulation
    Figure 72. Key Executives Interviewed